Brief: Neuroscientific Biopharmaceuticals Partners With International Cro Biospective For Multiple Sclerosis Studies
02/11/2021 01:21
Nov 2 (Reuters) - NeuroScientific Biopharmaceuticals Ltd
NSB.AX :
* PARTNERS WITH INTERNATIONAL CRO BIOSPECTIVE FOR MULTIPLE
SCLEROSIS STUDIES
Source text for Eikon: ID:nASX528HVz
Further company coverage: NSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO